Interaction of acute leukemia cells with the bone marrow microenvironment: implications for control of minimal residual disease.
about
Having a higher blast percentage in circulation than bone marrow: clinical implications in myelodysplastic syndrome and acute lymphoid and myeloid leukemiasAberrant expression of functional BAFF-system receptors by malignant B-cell precursors impacts leukemia cell survivalCD30 ligand (CD30L)-expressing acute myeloid leukemias: a new model of paracrine interactions for the regulation of blast cells proliferation.A functional receptor for B-cell-activating factor is expressed on human acute lymphoblastic leukemiasIdentification and targeting leukemia stem cells: The path to the cure for acute myeloid leukemia.Survival of B lineage leukemic cells: signals from the bone marrow microenvironment.Contribution of bone microenvironment to leukemogenesis and leukemia progression.Performance status in elderly patients with acute myeloid leukemia: exploring gene expression signatures of cytokines and chemokines.Regulation of lymphoid and myeloid leukemic cell survival: role of stromal cell adhesion molecules.The regulation of normal and leukemic hematopoietic stem cells by niches.Tetraspanin CD82 regulates bone marrow homing of acute myeloid leukemia by modulating the molecular organization of N-cadherinPhosphorylation of a constrained azacyclic FTY720 analog enhances anti-leukemic activity without inducing S1P receptor activation.Reciprocal leukemia-stroma VCAM-1/VLA-4-dependent activation of NF-κB mediates chemoresistance.Modulation of Tumor Cell Survival, Proliferation, and Differentiation by the Peptide Derived from Tenascin-C: Implication of β1-Integrin Activation.Role of integrin alpha4 in drug resistance of leukemiaContribution of very late antigen-4 (VLA-4) integrin to cancer progression and metastasis.Cancer stem cells and tumor-associated macrophages: a roadmap for multitargeting strategies.Apoptotic death of hematopoietic tumor cells through potentiated and sustained adhesion to fibronectin via VLA-4Plerixafor inhibits chemotaxis toward SDF-1 and CXCR4-mediated stroma contact in a dose-dependent manner resulting in increased susceptibility of BCR-ABL+ cell to Imatinib and Nilotinib.Activation of FGFR1beta signaling pathway promotes survival, migration and resistance to chemotherapy in acute myeloid leukemia cells.xCELLigence system for real-time label-free monitoring of growth and viability of cell lines from hematological malignancies.Chemotherapeutic treatment of bone marrow stromal cells strongly affects their protective effect on acute myeloid leukemia cell survival.Treatment of B-cell precursor acute lymphoblastic leukemia with the Galectin-1 inhibitor PTX008.Alterations of the bone marrow stromal microenvironment in adult patients with acute myeloid and lymphoblastic leukemias before and after allogeneic hematopoietic stem cell transplantation.Evaluation of biologic activity of tryptase secreted from blast cells in acute myeloid leukemia.
P2860
Q28264033-A2F7889C-F22F-4F37-ABF7-CD37CCEE0EA0Q28743862-564CC3DC-8347-4770-868F-DAF88D27B2D9Q33747241-39E294FF-DACD-4E7D-BC63-9EF005DD09AFQ33891940-67220049-6926-41C6-997A-2C48974F14D5Q34232877-79A01B65-66D8-4C09-884D-388C6B223165Q34573970-0797D796-03F8-48C1-A9A9-A2B409C0FCFAQ35037058-ADB8DFD3-F913-451B-9562-A69175D98C3CQ35661799-6CA5CA60-E94A-4448-8A15-410D118B5837Q35733270-E849B87C-C519-4D97-BC19-CDAB78E2A5A9Q36284911-2CDF0097-3CD2-4F07-A50F-A063BF56D6CFQ36927799-E1B41247-DEBB-4B4B-87F1-9460D0997FD9Q37675273-072B9DFF-C0BF-4DFE-B366-4BD94F62EE8DQ37723478-F8E64FC3-F0FD-4FCE-9829-3474F957C2F2Q37973062-AB10042C-D9BB-4481-8CF7-00CE0C155BAEQ38218126-25F7CCA8-9550-4D92-9BC2-C1C240FCD2A3Q38309552-9F613630-BF91-47DE-9A6A-B497790AB540Q38472322-A4E0EA63-F68B-43D5-9ED6-92CE838D3CB2Q39761913-B69AB0E2-78B5-4076-8A74-6AF4FAC2C079Q39816193-EB6E70CD-EC47-427B-89C8-FD64D082066CQ40295205-CB834167-033B-461C-B50A-928331D01846Q40815778-6017E1CD-01CD-43C7-8DA6-0997F6462193Q46958474-A882C612-F90E-476E-AC79-B3931357D48EQ52724033-C72C71ED-A3AB-4F41-849B-B9F3DD8DBD18Q53089081-1E00616B-D2FE-4197-82CF-E0C7B0D46056Q53345414-35318965-745F-4595-82FC-B156F0C6F1A0
P2860
Interaction of acute leukemia cells with the bone marrow microenvironment: implications for control of minimal residual disease.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Interaction of acute leukemia ...... l of minimal residual disease.
@en
type
label
Interaction of acute leukemia ...... l of minimal residual disease.
@en
prefLabel
Interaction of acute leukemia ...... l of minimal residual disease.
@en
P2860
P1433
P1476
Interaction of acute leukemia ...... l of minimal residual disease.
@en
P2093
Bradstock KF
Gottlieb DJ
P2860
P356
10.3109/10428199509064917
P577
1995-06-01T00:00:00Z